Tocagen TG 511-15-01 Glioma Skip To Content

Study ID: Tocagen TG 511-15-01 Glioma

Title:

A Phase 2/3 Randomized, Open-Label Study of Toca 511, a Retroviral Replicating Vector, Combined With Toca FC versus Standard of Care in Subjects Undergoing Planned Resection for Recurrent Glioblastoma or Anaplastic Astrocytoma

Location:
Sioux Falls Region
Principal Investigator:
Miroslaw Mazurczak, MD
Disease:
Brain and Nervous System
Stage:
Phase II/III
Status:
Active - Open to Accrual

For more information, call or email Bismarck Clinical Research at (701) 323-5760, Fargo and Bemidji Clinical Research at (701) 234-5890, or Sioux Falls Clinical Research at (605) 328-1368.